Thus, we measured MDK serum levels in women with LAM and healthy controls and found that MDK levels were 3.7-fold higher in LAM patients (n = 20) compared to healthy controls (n = 19) (p = 0.0361, Supplementary Fig. 5b). The gene discussed is MDK; the disease is lymphangioleiomyomatosis.